Gary Stephen May - May 6, 2022 Form 4 Insider Report for Leidos Holdings, Inc. (LDOS)

Role
Director
Signature
/s/ Ramune M. Kligys, Attorney-in-Fact
Stock symbol
LDOS
Transactions as of
May 6, 2022
Transactions value $
-$747,024
Form type
4
Date filed
5/10/2022, 05:00 PM
Previous filing
Feb 18, 2022
Next filing
May 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LDOS Common Stock Award $0 +1.11K +12.75% $0.00 9.78K May 6, 2022 Direct
transaction LDOS Common Stock Options Exercise $333K +10.5K +107.62% $31.62 20.3K May 9, 2022 Direct
transaction LDOS Common Stock Tax liability -$333K -3.22K -15.88% $103.21 17.1K May 9, 2022 Direct F1
transaction LDOS Common Stock Sale -$747K -7.3K -42.74% $102.35 9.78K May 9, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LDOS Stock Option (Right to Buy) Award $0 +1.78K $0.00 1.78K May 6, 2022 Common Stock 1.78K $104.06 Direct F3
transaction LDOS Stock Option (Right to Buy) Options Exercise $0 -10.5K -100% $0.00* 0 May 9, 2022 Common Stock 10.5K $31.62 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the issuer in connection with the option exercise to cover the exercise price and associated fees.
F2 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions from $102.23 to $102.65 inclusive. The reporting person undertakes to providing to Leidos Holdings, Inc., any security holder of Leidos Holdings, Inc., or the staff of the Securities Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the aforementioned range.
F3 The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.
F4 This stock option was previously reported as a stock option grant for 7,777 shares of common stock at an exercise price of $42.79 per share. The number of options and the exercise price were subsequently adjusted to reflect a special dividend declared by the issuer in August 2016.